Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
Revenue
Alliance Pharma PLC
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Revenue
£178.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Revenue
£31.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Revenue
$54.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
17%
|
CAGR 10-Years
7%
|
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Revenue
$42.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Revenue
$2.1B
|
CAGR 3-Years
36%
|
CAGR 5-Years
24%
|
CAGR 10-Years
7%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Revenue
$3.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
|
Alliance Pharma PLC
Glance View
Alliance Pharma Plc is a holding company, which engages in the acquisition, marketing, and distribution of healthcare and pharmaceutical products. The company is headquartered in Chippenham, Wiltshire and currently employs 255 full-time employees. The company went IPO on 2001-11-22. The firm is primarily engaged in the acquisition, marketing and distribution of healthcare and pharmaceutical products. The company is focused on two areas, which include Consumer Healthcare brands and Prescription Medicines. The Company’s Consumer Healthcare brands include Kelo-Cote, Nizoral, Amberen, MacuShield, Vamousse and Aloclair. Its Prescription Medicines include Hydromol, Flamma Franchise and Forceval. Its brands also include Ashton & Parsons and Anbesol. The Company’s products include Alliance Calcium Syrup, Amantadine hydrochloride, Aiweidi, Biodermatin, Biotaches, Buccastem M, Changmin, Decapional, Dermachronic, Dermacide, Dervida, Effadiane, Fazol, Gen-Ongles, Irenat, ISIB, Isocarboxazid, Jonctum, Kelo-Stretch, Lypsyl, Lefuzhi, Malunjunshe, MolluDab, Menadiol, Neostigmine and Nu-Seals. Its geographical area includes Europe, Middle East and Africa (EMEA), Asia Pacific and China (APAC) and Americas (AMER).
See Also
What is Alliance Pharma PLC's Revenue?
Revenue
178.8m
GBP
Based on the financial report for Dec 31, 2024, Alliance Pharma PLC's Revenue amounts to 178.8m GBP.
What is Alliance Pharma PLC's Revenue growth rate?
Revenue CAGR 10Y
15%
Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Alliance Pharma PLC have been 3% over the past three years , 6% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet